NBF LANES promotes functional health through safe, innovative, and high-quality feed solutions. Our extensive portfolio spans multiple clinical areas, offering supplements renowned for their proven efficacy, high palatability, and consistent results.

A cornerstone of our innovation is pioneering microbiota research. Since 2016, our dedicated studies led to a landmark achievement: the first EFSA authorization in Europe (2023) for species-specific Limosilactobacillus reuteri probiotics—DSM 32203 for dogs and DSM 32264 for cats. We continue to expand this legacy with the development of postbiotics like NBF DC PRO.

To develop innovative animal nutrition solutions with our proprietary raw materials and ingredients, visit → nbfreuteri.com/en/

Explore our product lines for cat, dogs and horses: 
 • Pet Line → nbflanes.com/en/
 • Horse Line → nbflaneshorse.com/?lang=en

NBF LANES

Org chart

Teams

Offices